HIGHLIGHTS
- who: Lu00e9a Flippe et al. from the UMR, Nantes, France have published the research: Generation of CD34+CD43+ Hematopoietic Progenitors to Induce Thymocytes from Human Pluripotent Stem Cells, in the Journal: Cells 2022, 4046 of /2022/
- how: For the differentiation of hPSCs to hematopoietic precursors the authors used an optimized serum- and feeder-free in_vitro differentiation protocol .
- future: Advances in immune cell engineering are opening up new perspectives for the generation of custom synthetic T_cells from hiPSCs.
SUMMARY
The clinical use of Teffs or Tregs has only been performed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.